The CIM is a closed-cycle biotechnological institution in charge of the research, development, production, and commercialization of scientific projects.

Havana, Jan 24 (RHC) Cuban Deputy Prime Minister Jorge Luis Perdomo met on Tuesday with US scientists from the Roswell Park Cancer Institute (RPCI), who are visiting Havana to expand collaboration with local institutions.

It is a very important visit because collaboration between the Roswell Park Cancer Institute and the Molecular Immunology Center (CIM) in Cuba is an example of what both countries can do despite the blockade against the Caribbean island, Perdomo said during the meeting.

The government official welcomed the fact that the Office of Foreign Assets Control (OFAC) of the United States Department of Treasury recently extended a license to continue cooperation until 2027.

Candace Johnson, President, and CEO of the Roswell Park Cancer Institute stressed that in recent years, a long journey has been covered in this project that has built a relationship of trust between the two institutions.

She added that Cuban scientists are very innovative and develop different approaches to problem-solving, so this cooperation can produce many good things for both parties.

Since 2011, the Roswell Park Cancer Institute and the CIM have carried out clinical studies of various products developed by the Cuban institution for cancer treatment.

The RPCI was founded in 1898 as the first center of its kind in the United States and today is a leader in cancer research in the world.

The CIM is a closed-cycle biotechnological institution in charge of research, development, production, and commercialization of scientific projects, especially for the treatment of cancer and other autoimmune diseases. (Source: Prensa Latina).